At hormonal levels—in line with the current literature—patients affected by OW and stages I–II of obesity demonstrated a progressive increase in leptin and insulin and a reduction in ghrelin (Figure 2), possibly impacting the imbalance of the taste signaling and food reward [54,55,56]. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.